voriconazole has been researched along with Febrile Neutropenia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Aguilar-Zapata, D; Barragán-Reyes, A; Camacho, A; Cendejas, RF; Cornejo-Juárez, P; Guzmán, JMF; Hernández, MLG; Jácome, LEL; Juárez-Hernández, E; Nava-Ruiz, A; Ontañón-Zurita, D; Perales-Martínez, D; Reséndiz-Sánchez, J; Rincón-Zuno, J; Rivera-Martínez, NE | 1 |
| Enoki, Y; Ikegame, K; Izumikawa, K; Matsumoto, K; Mayumi, T; Miyazaki, T; Miyazaki, Y; Okinaka, K; Takada, T; Takesue, Y; Uchino, M; Ueda, T; Yamashita, C | 1 |
| Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Kodama, K; Matsushima, S; Nakano, T; Sano, H; Suzuki, D; Yanagi, M | 1 |
| Liao, X; Luo, B; Wang, X; Wen, T; Zhao, J | 1 |
| Nguyen, JK; Pourciau, CY; Schady, D; Schlichte, MJ | 1 |
| Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L | 1 |
| Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
| Barnes, R; Bow, E; Charbonneau, C; Earnshaw, S; Herbrecht, R; Kantecki, M; Maertens, J; McDade, C; Morrissey, O; Schlamm, H; Slavin, M; Weinstein, D | 1 |
| Akan, H; Atilla, E | 1 |
| Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K | 1 |
| Cai, S; Guo, X; Ren, J; Yuan, W | 1 |
1 review(s) available for voriconazole and Febrile Neutropenia
| Article | Year |
|---|---|
Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Febrile Neutropenia; Humans; Mycoses; Randomized Controlled Trials as Topic; Treatment Outcome; Voriconazole | 2020 |
3 trial(s) available for voriconazole and Febrile Neutropenia
| Article | Year |
|---|---|
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
Topics: Adolescent; Adult; Aged; Antifungal Agents; China; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Survival Rate; Voriconazole; Young Adult | 2016 |
8 other study(ies) available for voriconazole and Febrile Neutropenia
| Article | Year |
|---|---|
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Fusariosis in Mexico: A 10-year retrospective series.
Topics: Amphotericin B; Antifungal Agents; Burns; Febrile Neutropenia; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Mexico; Retrospective Studies; Voriconazole | 2023 |
Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Voriconazole; Young Adult | 2021 |
Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Cytochrome P-450 CYP2C19; Febrile Neutropenia; Female; Genotype; Humans; Male; Middle Aged; Oxygenases; Pharmacogenomic Variants; Phenotype; Plasma; Polymorphism, Genetic; Potassium; Retrospective Studies; Serum; Tissue Distribution; Voriconazole | 2021 |
Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
Topics: Antifungal Agents; Antineoplastic Agents; Child; Drug Eruptions; Febrile Neutropenia; Fungemia; Humans; Immunocompromised Host; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon; Trichosporonosis; Voriconazole | 2018 |
Excavated pneumonia: an unusual suspect.
Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cost Savings; Decision Trees; Deoxycholic Acid; Drug Combinations; Echinocandins; Febrile Neutropenia; Galactose; Health Care Costs; Health Resources; Humans; Immunocompromised Host; Lipopeptides; Mannans; Survival Rate; Voriconazole | 2015 |
Antifungal Treatment in Stem Cell Transplantation Centers in Turkey.
Topics: Adult; Allografts; Amphotericin B; Antifungal Agents; Child; Cross Infection; Diagnostic Tests, Routine; Drug Substitution; Drug Therapy, Combination; Drug Utilization; Febrile Neutropenia; Health Care Surveys; Health Facilities; Humans; Infection Control; Mycoses; Stem Cell Transplantation; Transplantation, Autologous; Turkey; Voriconazole | 2016 |